New research suggests that, despite COVID-19 lockdown restrictions, diagnoses of sexually transmitted infections (STIs), including gonorrhea, secondary syphilis and mycoplasma genitalium have increased.
The research was presented at the 29th European Academy of Dermatology and Venereology (EADV) Congress, EADV Virtual, and the study was conducted in two main STI centers in Milan, Italy.
Researchers compared the number of confirmed diagnoses of common STIs in patients with symptoms from March 15, 2020 to April 14, 2020. They compared the data with that of the previous period in 2019.1
According to the findings, the number of acute bacterial infections, most associated with men who have sex with men, increased during the observational period, including secondary syphilis and gonorrhea. Cases fell in genital warts and Molluscum Contagiosum.1
The study concludes that despite social and physical distancing restrictions due to COVID-19, acute STIs increased.1
"It was assumed that the lockdown would reduce the opportunity for sexual encounters and STIs. However, I was surprised by the number of new acute infections diagnosed in this short period of time. Gonorrhea and syphilis are typically more prevalent in people in their 30s, so infection may have increased because the concentration of COVID-19 morbidity and mortality in the elderly made the younger, more active, cohort feel protected and so less risk averse,” said Marco Cusini, MD, of La Fondazione IRCCS Ca’ Granda Ospedale Maggiore di Milano Policlinico, in a press release.1
__
Reference
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
2 Commerce Drive
Cranbury, NJ 08512